Drugmakers see a pricing blueprint in an $850000 gene therapy – TODAYonline
TODAYonline |
Drugmakers see a pricing blueprint in an $850000 gene therapy
TODAYonline SAN FRANCISCO – Global drugmakers are looking to a tiny biotech's $850,000 therapy for a rare type of blindness as a model for getting paid for highly expensive – and effective – new medicines. Spark Therapeutics Inc <ONCE.O> plans to launch its … |
